Grahame COOK, Non-Executive Chairman

Grahame Cook joined the Board in 2004. He has over 18 years’ experience in investment banking, advising on a wide number of mergers and acquisitions and capital market transactions in the US and Europe. He was Global CEO of West LB Panmure, where he joined in 1999, Managing Director of Capital Markets and on the Global Investment Banking Committee at UBS. He has advised on a number of transactions in the pharmaceuticals and biotechnology sectors across Europe and the US, including private equity investments, IPOs and secondary offerings. Grahame Cook was a founder member of the LSE’s TechMARK Advisory Committee, and holds an MA, double first, from Oxford University. He is currently a Non-Executive Director of Antisonna plc.

Stuart SWANSON, Non-Executive Director

As one of the two founders of the specialty pharmaceutical company PharmaSwiss SA, Stuart Swanson worked in a variety of leadership roles in that company over the last ten years, including both operations and driving corporate strategy, investor relations and business development. At the time of PharmaSwiss’ sale to Valeant International on March 10th, 2011 he was President of Corporate Development and Board Member of the company. Since Valeant’s purchase of PharmaSwiss, Stuart Swanson has continued to work part time for Valeant as a Consultant.

Prior to joining PharmaSwiss in 2001, Swanson held a series of senior operational and regional HQ positions for Bristol-Myers Squibb (BMS) in Central Europe and Israel. Prior to BMS, he served as Pfizer’s first General Manager in Russia & CIS, opening Pfizer’s first affiliates in Russia, Kazakhstan, Uzbekistan and Turkmenistan. Stuart Swanson began his professional career as a US diplomat, serving as a Political Officer in Pakistan and Leningrad / St. Petersburg. He received a BA from Yale College and an MA from Columbia University, and grew up in the UK, where he attended Cranleigh School. Stuart Swanson also serves on the boards of a several private companies in real estate development and transportation.

Jean-Charles TSCHUDIN, Non-Executive Director

Jean-Charles Tschudin joined the Board in November 2007. He has extensive experience in the pharmaceutical industry at a senior executive level on three continents. He was recently President and Chief Operating Officer of Yamanouchi Europe, the largest Japanese company in Europe (now Astellas). He has also held senior positions at Johnson & Johnson, Schering-Plough, Syntex and Cardinal Health. Jean-Charles Tschudin is currently Non-Executive Director of SkyePharma plc and he also consults for the pharma industry.

Tim WRIGHT, Non-Executive Director

Tim Wright, aged 45, was appointed Chief Executive Officer of IS Pharma in October 2005. With over 20 years’ experience in the pharmaceutical industry, Tim has held senior commercial positions at Pfizer Ltd and SmithKline Beecham both domestically and internationally. Prior to IS Pharma, Tim was with Elan Pharmaceuticals where he was General Manager for Ireland and vice president, International Marketing. During his time at Elan, Tim was instrumental in the establishment, significant growth and ultimate successful divestment of its European business. Tim is a Fellow of the Chartered Institute of Marketing, a Fellow of the Institute of Directors and a Chartered Director.

Chris SPOONER, Chief Executive Officer

Chris Spooner was appointed CEO of Sinclair Pharma in December 2009. He has 15 years’ experience in analysing and investing in life science companies, having been a top-rated pharmaceuticals analyst at various investment banks, including JP Morgan, Deutsche Bank, Donaldson Lufkin & Jenrette and Bank of America. Prior to joining Sinclair he was the founding partner and CEO of HealthCor Management UK LLP, the European division of HealthCor LP, a leading New York based specialist healthcare fund. He holds an MA in Economics from King’s College, Cambridge.

Christophe FOUCHER, Chief Operating Officer

Christophe Foucher joined the Board of Sinclair in December 2009, having been appointed Chief Operating Officer in May 2009. He is responsible for all commercial supply chain and manufacturing activities in the Group. Prior to this he held the positions of General Manager for Sinclair Pharma France and Southern Europe Director, in charge of operations in Italy and Spain. Christophe Foucher has 17 years' experience in the pharmaceutical industry at senior level in Europe, Africa and Asia. He has a doctorate degree in Pharmacy, an INSEAD diploma in Finance and an MBA from IAE. He is fluent in English, French and Italian.